Compare FLL & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLL | ORMP |
|---|---|---|
| Founded | 1987 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.7M | 104.6M |
| IPO Year | 1993 | N/A |
| Metric | FLL | ORMP |
|---|---|---|
| Price | $2.88 | $3.09 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 160.2K | ★ 272.5K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $299,916,000.00 | $2,000,000.00 |
| Revenue This Year | $4.94 | N/A |
| Revenue Next Year | $7.83 | N/A |
| P/E Ratio | ★ N/A | $2.99 |
| Revenue Growth | ★ 7.45 | N/A |
| 52 Week Low | $2.25 | $1.82 |
| 52 Week High | $5.59 | $3.20 |
| Indicator | FLL | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 56.75 | 74.63 |
| Support Level | $2.61 | $2.66 |
| Resistance Level | $3.25 | $3.20 |
| Average True Range (ATR) | 0.18 | 0.16 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 52.84 | 81.92 |
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.